title: [The treatment of secondary Sjogren syndrome].
abstract: Sjogren syndrome is a chronic autoimmune disease witch affects mostly lachrymal and salivary glands. The exocrinopathy can be encountered alone (primary Sjogren syndrome) or in association with other autoimmune disorders (secondary Sjogren syndrome). Visual prognosis of the patients with secondary Sjogren syndrome depends on the early diagnosis, applied therapy follow-up controls along with an effective collaboration between ophthalmologist and rheumatologist. We present therapeutic options in secondary Sjogren syndrome: hygiene and protective measures, medical nonspecific substitution treatment, treatment to stimulate tear secretion, autoimmune disease-specific medical treatment and surgery.
authors.affiliation: Clinica de Oftalmologie, Tg-Mureş. FLORINA_DOC@YAHOO.COM
authors.forename: Florina
authors.initials: F
authors.lastname: Vultur
authors.forename: Angela
authors.initials: A
authors.lastname: Borda
authors.forename: Karin
authors.initials: K
authors.lastname: Horvath
authors.forename: Ildikó
authors.initials: I
authors.lastname: Máté-István
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000628:therapy; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D042241:Early Diagnosis; D005782:Gels / Q000008:administration & dosage; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009824:Ointments / Q000008:administration & dosage; D009883:Ophthalmic Solutions / Q000008:administration & dosage; D011379:Prognosis; D000069283:Rituximab; D012859:Sjogren's Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000601:surgery / Q000628:therapy*; D016896:Treatment Outcome; D014801:Vitamin A / Q000008:administration & dosage; D014815:Vitamins / Q000008:administration & dosage
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D005782:Gels; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D009824:Ointments; D009883:Ophthalmic Solutions; D014815:Vitamins; D014801:Vitamin A; D000069283:Rituximab; D016572:Cyclosporine